サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1426466

クロマチン免疫沈降（ChIP）シーケンシングの世界市場レポート 2024

Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
クロマチン免疫沈降（ChIP）シーケンシングの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

クロマチン免疫沈降（ChIP）シーケンシングの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には12.5%の年間複合成長率（CAGR）で222億6,000万米ドルに成長すると予想されます。予測期間で予想される成長は、業界の投資と競合の増加、診断アプリケーションの臨床採用の増加、バイオマーカー発見の需要、バイオインフォマティクスツールの急速な開発、クロマチン免疫沈降（ChIP）シーケンシングを使用した創薬アプリケーションの拡大に起因すると考えられます。予測期間中に予想される主な動向としては、ChIPシーケンシングの臨床および診断用途への応用、ヒストン修飾への注目の高まり、新規調査分野への応用、サンプル調製技術の進歩、マルチオミクスアプローチの統合などが挙げられます。

クロマチン免疫沈降（ChIP）シーケンシング市場の成長は、前立腺がんの有病率の増加によって促進されると予想されます。前立腺に発生する前立腺がんは、市場の拡大に寄与すると期待されています。 ChIP-seqは、前立腺がんに影響を与える分子事象の包括的な理解を提供することで、前立腺がんの調査において重要な役割を果たします。この情報は、その生物学の理解を進め、より標的を絞った治療介入を開発するために非常に重要です。 2023年 1月、米国がん協会は、米国における前立腺がんの新規症例数が推定288,300人、死亡者数が34,700人であると報告し、この健康上の懸念に対処する上でのChIP-seqの重要性を強調しました。

クロマチン免疫沈降（ChIP）シーケンシング市場の成長は、個別化医療の導入増加によって促進されると予想されます。個別化医療は、個々の患者の特性に合わせて医療上の決定を行うもので、疾患に関連する特定の遺伝的マーカーまたはエピジェネティックなマーカーを特定することに依存しています。 ChIPシーケンスは、疾患の遺伝的基盤を理解するために重要なエピジェネティック修飾をマッピングするための強力なツールであることが証明されています。 2022年にFDAの医薬品評価研究センターによって37の新規分子実体が承認され、その34%が個別化医療連合によって個別化医療に指定されており、個別化医療の進歩におけるクロマチン免疫沈降（ChIP）シーケンシングの役割が浮き彫りになっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のクロマチン免疫沈降（ChIP）シーケンシング市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • DNaseシーケンス
  • FAIREシーケンス
  • 世界のクロマチン免疫沈降（ChIP）シーケンシング市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ターゲットシーケンシングと再シーケンシング
  • 全ゲノムシーケンスと全エクソームシーケンス
  • 世界のクロマチン免疫沈降（ChIP）シーケンシング市場、ワークフロー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • プリシーケンス
  • シーケンス
  • データ分析
  • 世界のクロマチン免疫沈降（ChIP）シーケンシング市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 消耗品と試薬
  • サービス
  • その他の用途
  • 世界のクロマチン免疫沈降（ChIP）シーケンシング市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 学術研究機関
  • 臨床研究機関
  • 病院と診療所
  • 製薬会社およびバイオテクノロジー企業
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界のクロマチン免疫沈降（ChIP）シーケンシング市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のクロマチン免疫沈降（ChIP）シーケンシング市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • クロマチン免疫沈降（ChIP）シーケンシング市場の競合情勢
  • クロマチン免疫沈降（ChIP）シーケンシング市場の企業プロファイル
    • F. Hoffmann La Roche Ltd.
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Becton Dickinson and Co.
    • Eurofins Scientific SE

第31章 その他の大手および革新的な企業

  • Agilent Technologies Inc.
  • Illumina Inc.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Bio-Techne Corp.
  • BGI Genomics Co. Ltd.
  • Promega Corporation
  • GenScript Biotech Corporation
  • Abcam plc
  • BioLegend Inc.
  • Hamilton Co.
  • Takara Bio Inc.
  • Novogene Co. Ltd.
  • Oxford Nanopore Technologies plc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13478

Chromatin immunoprecipitation (ChIP) sequencing is a powerful molecular biology technique employed to investigate the interactions between proteins and DNA within a cell, offering insights into the binding patterns of specific proteins, often transcription factors or other chromatin-associated proteins, to DNA in a genome-wide manner.

The main types of ChIP sequencing include DNase-sequencing and Faire-sequencing. DNase-sequencing, commonly known as DNase-seq, is a molecular biology technique designed to assess the accessibility of DNA within the genome. It utilizes various technologies such as targeted sequencing, re-sequencing, whole genome sequencing, and whole exome sequencing for pre-sequencing, sequencing, and data analysis. The applications of DNase-seq encompass consumables and reagents, services, and other related components. The technique finds usage in academic research institutes, clinical research institutes, hospitals and clinics, pharmaceuticals and biotechnology companies, among others.

The chromatin immunoprecipitation (ChIP) sequencing market research report is one of a series of new reports from The Business Research Company that provides chromatin immunoprecipitation (ChIP) sequencing market statistics, including chromatin immunoprecipitation (ChIP) sequencing industry global market size, regional shares, competitors with a chromatin immunoprecipitation (ChIP) sequencing market share, detailed chromatin immunoprecipitation (ChIP) sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the chromatin immunoprecipitation (ChIP) sequencing industry. This chromatin immunoprecipitation (ChIP) sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chip sequencing market size has grown rapidly in recent years. It will grow from $12.36 billion in 2023 to $13.89 billion in 2024 at a compound annual growth rate (CAGR) of 12.4%. The growth observed during the historical period can be attributed to advancements in understanding gene regulation, a rise in epigenetics studies, improvements in data analysis and bioinformatics tools, and the associated cost reduction and scalability in Chromatin Immunoprecipitation (ChIP) sequencing techniques.

The chip sequencing market size is expected to see rapid growth in the next few years. It will grow to $22.26 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The anticipated growth in the forecast period can be attributed to increased industry investment and competition, growing clinical adoption for diagnostic applications, a demand for biomarker discovery, rapid development in bioinformatics tools, and expanded applications in drug discovery using Chromatin Immunoprecipitation (ChIP) sequencing. Major trends expected during the forecast period include the translation of ChIP sequencing into clinical and diagnostic applications, a heightened focus on histone modifications, application in novel research areas, advancements in sample preparation techniques, and the integration of multi-omics approaches.

The growth of the chromatin immunoprecipitation (ChIP) sequencing market is expected to be driven by the increasing prevalence of prostate cancer. Prostate cancer, which originates in the prostate gland, is anticipated to contribute to the market's expansion. ChIP-seq plays a vital role in prostate cancer research by providing a comprehensive understanding of the molecular events influencing the disease. This information is crucial for advancing the understanding of its biology and developing more targeted therapeutic interventions. In January 2023, the American Cancer Society reported an estimated 288,300 new cases of prostate cancer and 34,700 deaths in the US, emphasizing the significance of ChIP-seq in addressing this health concern.

The growth of the chromatin immunoprecipitation (ChIP) sequencing market is expected to be propelled by the increasing adoption of personalized medicine. Personalized medicine, which tailors medical decisions to individual patient characteristics, relies on identifying specific genetic or epigenetic markers associated with diseases. ChIP sequencing proves to be a powerful tool in mapping epigenetic modifications crucial for understanding the genetic basis of diseases. In 2022, the approval of 37 novel molecular entities by the FDA's Center for Drug Evaluation and Research, with 34% designated as tailored medications by the Personalized Medicine Coalition, highlights the role of ChIP sequencing in advancing personalized medicine.

The high cost of ChIP-sequencing technology is anticipated to hinder market growth. The substantial expenses associated with ChIP-Seq experiments, approximately $550 per sample, may limit the number of samples processed, slowing down research progress. This cost factor may impede the technology's adoption in therapeutic settings where cost-effectiveness is a critical consideration. While ChIP-Seq is considered more cost-effective than alternative methods, its expense, influenced by factors such as genome size and sequencing depth, remains a limiting factor for broader implementation.

Major companies in the chromatin immunoprecipitation (ChIP) sequencing market are addressing consumer needs through innovative products, such as molecular electronics chips. These chips, utilizing single molecules or molecular assemblies for electronic functions, aim to enhance research capabilities. For instance, Roswell Biotechnologies launched the Roswell ME Chip in November 2021, offering a flexible and potent tool for examining oligos and biological dynamics related to DNA and polymerase binding. This chip's potential applications extend across various industries, including fundamental science, environmental monitoring, and healthcare.

In August 2021, ProPhase Labs Inc., a US-based biotechnology company, acquired Nebula Genomics for $14.6 million. This strategic acquisition aligns with ProPhase's goal to better support individuals seeking assistance in diagnosing genetically impacted conditions. Nebula Genomics, known for its web service analyzing ChIP-sequencing (ChIP-Seq) data, contributes to ProPhase's commitment to advancing genetic diagnostics for various health concerns.

Major companies operating in the chromatin immunoprecipitation (chip) sequencing market report are F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc. , Becton Dickinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc. , PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Porvair Sciences Ltd. , Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., EpiCypher Inc.

North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chromatin immunoprecipitation (chip) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chromatin immunoprecipitation (chip) sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The chromatin immunoprecipitation (ChIP) sequencing market consists of revenues earned by entities by providing services such as ChIP sample preparation, library preparation and sequencing, bioinformatics analysis, customization and consultation, data interpretation and reporting, and quality control, and assurance. The market value includes the value of related goods sold by the service provider or included within the service offering. The ChIP sequencing market also includes sales of ChIP kits, antibodies, DNA library preparation kits, sequencing kits, chromatin shearing equipment, and epigenetic modification kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chromatin immunoprecipitation (ChIP) sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chromatin immunoprecipitation (Chip) sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chromatin immunoprecipitation (chip) sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: DNase-Sequencing; FAIRE-Sequencing
  • 2) By Technology: Targeted Sequencing And Re-Sequencing; Whole Genome Sequencing And Whole Exome Sequencing
  • 3) By Workflow: Pre-Sequencing; Sequencing; Data Analysis
  • 4) By Application: Consumables And Reagents; Service; Other Applications
  • 5) By End-User: Academic Research Institutes; Clinical Research Institutes; Hospitals And Clinics; Pharmaceuticals And Biotechnology Companies; Other End Users
  • Companies Mentioned: F. Hoffmann La Roche Ltd.; Merck KGaA; Thermo Fisher Scientific Inc. ; Becton Dickinson and Co.; Eurofins Scientific SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chromatin Immunoprecipitation (ChIP) Sequencing Market Characteristics

3. Chromatin Immunoprecipitation (ChIP) Sequencing Market Trends And Strategies

4. Chromatin Immunoprecipitation (ChIP) Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Size and Growth

  • 5.1. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Chromatin Immunoprecipitation (ChIP) Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Chromatin Immunoprecipitation (ChIP) Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Chromatin Immunoprecipitation (ChIP) Sequencing Market Segmentation

  • 6.1. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • DNase-Sequencing
  • FAIRE-Sequencing
  • 6.2. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Targeted Sequencing And Re-Sequencing
  • Whole Genome Sequencing And Whole Exome Sequencing
  • 6.3. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pre-Sequencing
  • Sequencing
  • Data Analysis
  • 6.4. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables And Reagents
  • Service
  • Other Applications
  • 6.5. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic Research Institutes
  • Clinical Research Institutes
  • Hospitals And Clinics
  • Pharmaceuticals And Biotechnology Companies
  • Other End Users

7. Chromatin Immunoprecipitation (ChIP) Sequencing Market Regional And Country Analysis

  • 7.1. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 8.1. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 9.1. China Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 9.2. China Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 10.1. India Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 11.1. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 11.2. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 12.1. Australia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 13.1. Indonesia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 14.1. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 14.2. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 15.1. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 15.2. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 16.1. UK Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 17.1. Germany Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 18.5. France Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 19.9. Italy Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 20.13. Spain Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 21.1. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 21.2. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 22.1. Russia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 23.1. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 23.2. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 24.1. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 24.2. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 25.1. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 25.2. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 26.1. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 26.2. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 27.1. Brazil Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 28.1. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 28.2. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 29.1. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 29.2. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Landscape
  • 30.2. Chromatin Immunoprecipitation (ChIP) Sequencing Market Company Profiles
    • 30.2.1. F. Hoffmann La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck KGaA
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton Dickinson and Co.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Eurofins Scientific SE
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Chromatin Immunoprecipitation (ChIP) Sequencing Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Illumina Inc.
  • 31.3. PerkinElmer Inc.
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. Qiagen N.V.
  • 31.6. Bio-Techne Corp.
  • 31.7. BGI Genomics Co. Ltd.
  • 31.8. Promega Corporation
  • 31.9. GenScript Biotech Corporation
  • 31.10. Abcam plc
  • 31.11. BioLegend Inc.
  • 31.12. Hamilton Co.
  • 31.13. Takara Bio Inc.
  • 31.14. Novogene Co. Ltd.
  • 31.15. Oxford Nanopore Technologies plc

32. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Benchmarking

33. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Chromatin Immunoprecipitation (ChIP) Sequencing Market

35. Chromatin Immunoprecipitation (ChIP) Sequencing Market Future Outlook and Potential Analysis

  • 35.1 Chromatin Immunoprecipitation (ChIP) Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Chromatin Immunoprecipitation (ChIP) Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Chromatin Immunoprecipitation (ChIP) Sequencing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer